Nektar Therapeutics | NKTR - Acreedores Comerciales

Precio De Mercado
77.50
Cambio Diario
-0.35 -0.45%
Mensual
5.69%
Anual
736.44%
Q2 Expectativa
75.38




Acreedores Comerciales Cambio Fecha
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
ALKERMES USD 107.95M 39.95M 2025-12
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Amgen USD 20.89B 1.25B 2025-12
Baxter International USD 999M 46M 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Biogen USD 432M 18.9M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Cara Therapeutics USD 4.08M 1.65M 2025-09
Cipla INR 30.35B 1.98B 2025-09
Dr.Reddys Laboratories INR 40.8B 548M 2025-12
Eisai JPY 85.49B 4.76B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Exelixis USD 29.62M 4.27M 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
Karyopharm Therapeutics USD 4M 1.39M 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
Merck USD 4.15B 102M 2025-09
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Xencor USD 10.83M 1.75M 2025-12